Novartis
NVS
#58
Rank
HK$1.604 T
Marketcap
HK$802.35
Share price
-0.17%
Change (1 day)
8.10%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2024 (TTM): HK$99.36 Billion

According to Novartis's latest financial reports the company's current earnings are HK$49.94 Billion. In 2023 the company made an earning of HK$71.00 Billion, an increase over its 2022 earnings that were of HK$62.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$99.36 B39.94%
2023 HK$71.00 B13.48%
2022 HK$62.56 B-69.24%
2021 HK$203.42 B164.6%
2020 HK$76.88 B10.49%
2019 HK$69.58 B-36.26%
2018 HK$109.16 B55.86%
2017 HK$70.03 B15.12%
2016 HK$60.83 B-3.9%
2015 HK$63.30 B-33.72%
2014 HK$95.51 B14.87%
2013 HK$83.14 B-2.93%
2012 HK$85.65 B2.15%
2011 HK$83.84 B-7.94%
2010 HK$91.07 B17.94%
2009 HK$77.22 B4.45%
2008 HK$73.93 B27.5%
2007 HK$57.98 B-6.31%
2006 HK$61.89 B9.46%
2005 HK$56.54 B5.17%
2004 HK$53.76 B13.84%
2003 HK$47.22 B-38.51%
2002 HK$76.80 B574.04%
2001 HK$11.39 B83%
2000 HK$6.22 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$128.34 B 29.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.44 Billion-109.52%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.16 B 44.48%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.65 B-41.82%๐Ÿ‡ซ๐Ÿ‡ท France
HK$32.46 B-67.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$6.43 B-93.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-HK$53.55 Billion-154.04%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.75 B-46.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$73.17 B-26.15%๐Ÿ‡ฌ๐Ÿ‡ง UK